2fhy: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{STRUCTURE_2fhy| PDB=2fhy | SCENE= }} | {{STRUCTURE_2fhy| PDB=2fhy | SCENE= }} | ||
===Structure of human liver FPBase complexed with a novel benzoxazole as allosteric inhibitor=== | ===Structure of human liver FPBase complexed with a novel benzoxazole as allosteric inhibitor=== | ||
{{ABSTRACT_PUBMED_16442285}} | {{ABSTRACT_PUBMED_16442285}} | ||
| Line 14: | Line 10: | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:016442285</ref><ref group="xtra">PMID:016446092</ref><references group="xtra"/> | <ref group="xtra">PMID:016442285</ref><ref group="xtra">PMID:016446092</ref><references group="xtra"/><references/> | ||
[[Category: Fructose-bisphosphatase]] | [[Category: Fructose-bisphosphatase]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
Revision as of 05:26, 25 March 2013
Structure of human liver FPBase complexed with a novel benzoxazole as allosteric inhibitor
Template:ABSTRACT PUBMED 16442285
About this Structure
2fhy is a 4 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- von Geldern TW, Lai C, Gum RJ, Daly M, Sun C, Fry EH, Abad-Zapatero C. Benzoxazole benzenesulfonamides are novel allosteric inhibitors of fructose-1,6-bisphosphatase with a distinct binding mode. Bioorg Med Chem Lett. 2006 Apr 1;16(7):1811-5. Epub 2006 Jan 25. PMID:16442285 doi:10.1016/j.bmcl.2006.01.015
- Lai C, Gum RJ, Daly M, Fry EH, Hutchins C, Abad-Zapatero C, von Geldern TW. Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase. Bioorg Med Chem Lett. 2006 Apr 1;16(7):1807-10. Epub 2006 Jan 30. PMID:16446092 doi:10.1016/j.bmcl.2006.01.014
